RIVM to begin systematic measuring of ultrafine particles in 2023 In 2023, RIVM will take systematic measurements of ultrafine particles in the outside air for the first time. This is necessary because little is known at present about ultrafine particles and their potential health effects. Ultrafine particles must be measured with different equipment than that usually used for particulate matter.
RIVM publishes new data from manufacturers on tobacco products On behalf of the Dutch Ministry of VWS (Health, Welfare and Sport), RIVM has published new data on tobacco products. For the first time, these data include the ingredients of e-cigarettes, heated tobacco products and herbal smoking products.
No indication that investigated mesh implants used to treat pelvic organ prolapse are unsafe RIVM has conducted a laboratory study into six mesh implants from different manufacturers used in the Netherlands in 2018. The study revealed no indication that these products are unsafe for patients.
Exposure to combination of chemicals appears to be too high, health risks unclear The food and drinking water that people consume include chemicals that have effects on health. Among them are substances, such as lead, which are known to have a negative effect on intelligence or development of the brain.
Changed indicative magnetic field zones around overhead high-voltage lines RIVM has updated the 2005 grid map (Netkaart) showing the overhead high-voltage lines in the Netherlands.
INHERIT Model: a tool to jointly improve health, environmental sustainability and Health Equity RIVM is involved in the Horizon2020 project INHERIT. The first article of the INHERIT project has been published, lead-authored by RIVM.
RIVM on shortlist Best Government Organisation of the Year 2018 The National Institute for Public Health and the Environment (RIVM) has made the shortlist for the 2018 election for best government organisation of the year.
RIVM supports WHO in national capacity building for measuring foodborne disease burden RIVM’s Collaborating Centre for Risk Assessment of Pathogens in Food and Water was invited to WHO’s side event during the 41st Codex Alimentarius Commission on July 4th 2018.
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.
Meningococcal disease serious, but still rare Meningococcal disease is a disease caused by a bacterium, the meningococcus. There are several types of this bacterium. In most cases, it does not make you ill.